Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 113, Issue 11, 2012, Pages 3436-3445

  Lim, Seyoung ^a   Jang, Hyun Jun ^a,b   Park, Eun Hee ^b   Kim, Jung Kuk ^a,b   Kim, Jung Min ^a,b   Kim, Eung Kyun ^a   Yea, Kyungmoo ^b   Kim, Yun Hee ^c   Lee Kwon, Whaseon ^a   Ryu, Sung Ho ^b   Suh, Pann Ghill ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

ADIPOGENESIS; MESENCHYMAL STEM CELLS; WEDELOLACTONE

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CCAAT ENHANCER BINDING PROTEIN ALPHA; FAT DROPLET; FATTY ACID BINDING PROTEIN 4; LIPOPROTEIN LIPASE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; WEDELOLACTONE;

ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ADULT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOCYTES; ADIPOGENESIS; ADULT; ANTI-OBESITY AGENTS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; COUMARINS; FATTY ACID-BINDING PROTEINS; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEIN LIPASE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PPAR GAMMA; PRIMARY CELL CULTURE; SUBCUTANEOUS FAT;

EID: 84866503308     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24220     Document Type: Article

References (43)

1. Camp HS, Tafuri SR,. 1997. Regulation of peroxisome proliferator- activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem 272: 10811-10816.
2. Camp HS, Tafuri SR, Leff T,. 1999. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity. Endocrinology 140: 392-397.
3. Chen J, Giovannucci E, Hankinson SE, Ma J, Willett WC, Spiegelman D, Kelsey KT, Hunter DJ,. 1998. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19: 2129-2132.
4. Chen TH, Chen WM, Hsu KH, Kuo CD, Hung SC,. 2007. Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 355: 913-918.
5. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH,. 2007. Hyperglycemia enhances adipogenic induction of lipid accumulation: Involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling. Endocrinology 148: 4267-4275.
6. Crews CM, Alessandrini A, Erikson RL,. 1992. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258: 478-480.
7. Emre N, Coleman R, Ding S,. 2007. A chemical approach to stem cell biology. Curr Opin Chem Biol 11: 252-258.
8. Fu L, Tang T, Miao Y, Zhang S, Qu Z, Dai K,. 2008. Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation. Bone 43: 40-47.
9. Fuentes P, Acuna MJ, Cifuentes M, Rojas CV,. 2010. The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1,2 activation and PPARG phosphorylation. J Endocrinol 206: 75-83.
10. Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA,. 2005. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48: 1416-1423.
11. Gupta V, Bhasin S, Guo W, Singh R, Miki R, Chauhan P, Choong K, Tchkonia T, Lebrasseur NK, Flanagan JN, Hamilton JA, Viereck JC, Narula NS, Kirkland JL, Jasuja R,. 2008. Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol 296: 32-40.
12. Harp JB,. 2004. New insights into inhibitors of adipogenesis. Curr Opin Lipidol 15: 303-307.
13. Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P, Hunziker W, Weber P, Martin I, Bendik I,. 2004. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 145: 848-859.
14. Hu E, Kim JB, Sarraf P, Spiegelman BM,. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274: 2100-2103.
15. Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W, Qin Y,. 2006. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem Biophys Res Commun 348: 571-578.
16. Kaushik-Basu N, Bopda-Waffo A, Talele TT, Basu A, Costa PR, da Silva AJ, Sarafianos SG, Noel F,. 2008. Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Nucleic Acids Res 36: 1482-1496.
17. Kim MH, Park JS, Seo MS, Jung JW, Lee YS, Kang KS,. 2010a. Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/beta-catenin signalling or lipolysis. Cell Prolif 43: 594-605.
18. Kim SD, Park RY, Kim YR, Kim IJ, Kang TW, Nam KI, Ahn KY, Bae CS, Kim BY, Park SS, Jung C,. 2010b. HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression. Anat Cell Biol 43: 284-293.
19. Kobori M, Yang Z, Gong D, Heissmeyer V, Zhu H, Jung YK, Gakidis MA, Rao A, Sekine T, Ikegami F, Yuan C, Yuan J,. 2004. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ 11: 123-130.
20. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA,. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870.
21. Lee H, Kang R, Hahn Y, Yang Y, Kim SS, Cho SH, Chung SI, Yoon Y,. 2009. Antiobesity effect of baicalin involves the modulations of proadipogenic and antiadipogenic regulators of the adipogenesis pathway. Phytother Res 23: 1615-1623.
22. Levenson AS, Jordan VC,. 1997. MCF-7: The first hormone-responsive breast cancer cell line. Cancer Res 57: 3071-3078.
23. Lim S, Jang HJ, Kim JK, Kim JM, Park EH, Yang JH, Kim YH, Yea K, Ryu SH, Suh PG,. 2011. Ochratoxin A inhibits adipogenesis through the extracellular signal-related kinases-peroxisome proliferator-activated receptor-gamma pathway in human adipose tissue-derived mesenchymal stem cells. Stem Cells Dev 20: 415-426.
24. Lin FM, Chen LR, Lin EH, Ke FC, Chen HY, Tsai MJ, Hsiao PW,. 2007. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells. Carcinogenesis 28: 2521-2529.
25. Ling HY, Wen GB, Feng SD, Tuo QH, Ou HS, Yao CH, Zhu BY, Gao ZP, Zhang L, Liao DF,. 2011. MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling. Clin Exp Pharmacol Physiol 38: 239-246.
26. Liu ZJ, Zhuge Y, Velazquez OC,. 2009. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106: 984-991.
27. Mors WB, do Nascimento MC, Parente JP, da Silva MH, Melo PA, Suarez-Kurtz G,. 1989. Neutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae). Toxicon 27: 1003-1009.
28. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y, Matsumoto T,. 2002. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 143: 2349-2356.
29. O'Mahony OA, Steinkamp MP, Albertelli MA, Brogley M, Rehman H, Robins DM,. 2008. Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer. Mol Cancer Res 6: 1691-1701.
30. Phrakonkham P, Viengchareun S, Belloir C, Lombes M, Artur Y, Canivenc-Lavier MC,. 2008. Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J Steroid Biochem Mol Biol 110: 95-103.
31. Robinson MJ, Cobb MH,. 1997. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186.
32. Schugar RC, Robbins PD, Deasy BM,. 2008. Small molecules in stem cell self-renewal and differentiation. Gene Ther 15: 126-135.
33. Seger R, Krebs EG,. 1995. The MAPK signaling cascade. FASEB J 9: 726-735.
34. Semirale AA, Zhang XW, Wiren KM,. 2011. Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J Cell Biochem 112: 1773-1786.
35. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S,. 2003. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144: 5081-5088.
36. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S,. 2006. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147: 141-154.
37. Szelei J, Jimenez J, Soto AM, Luizzi MF, Sonnenschein C,. 1997. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138: 1406-1412.
38. Takeuchi S, Takahashi T, Sawada Y, Iida M, Matsuda T, Kojima H,. 2009. Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol Pharm Bull 32: 195-202.
39. Tominaga S, Yamaguchi T, Takahashi S, Hirose F, Osumi T,. 2005. Negative regulation of adipogenesis from human mesenchymal stem cells by Jun N-terminal kinase. Biochem Biophys Res Commun 326: 499-504.
40. Wagner H, Geyer B, Kiso Y, Hikino H, Rao GS,. 1986. Coumestans as the main active principles of the liver drugs eclipta alba and Wedelia calendulacea. Planta Med 52: 370-374.
41. Wang T, Wang Y, Kontani Y, Kobayashi Y, Sato Y, Mori N, Yamashita H,. 2008. Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling. Endocrinology 149: 358-366.
42. Wilson VS, Bobseine K, Gray LE, Jr., 2004. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicol Sci 81: 69-77.
43. Zhou S, Lechpammer S, Greenberger JS, Glowacki J,. 2005. Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling. J Biol Chem 280: 22688-22696.